Stay informed with the latest litigation news. Explore now

IP Verse

(1R, 2R)-3-(Dimenthyl Amino-1-Ethyl-2-Methyl-Propyl) Phenol For Treating Painful Inflammations - EP3241550B1

EP3241550

GRNENTHAL
Application Number
EP17020237A
Filing Date
Nov 18, 2003
Status
Revoked
Feb 23, 2024
Grant Date
Jul 22, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3995135B1
EP3210965B1
EP3656765B1

Bibliography

The patent EP3241550B1 was granted to Grnenthal on Jul 22, 2020 following the initial filing on Nov 18, 2003 under the application number EP17020237A . The current legal status of the patent is Revoked.

Patent Summary (AI Generated) New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKApr 22, 2021ADMISSIBLE
TEVA PHARMACEUTICALSApr 21, 2021WITHDRAWN
HEXALApr 20, 2021WITHDRAWN
DR SCHONApr 16, 2021WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents